Plain-English translation of NCT05001087 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Multiple Myeloma research guide →This is a registry study — meaning it collects real-world information about myeloma patients and their care rather than testing a new medication. Researchers want to gather data from patients diagnosed since January 2019 to understand how myeloma is currently being diagnosed and treated across Italy. By participating, you help doctors learn what works best and identify ways to improve care for future patients.
Italy does not yet have a national myeloma registry, even though other countries do. Creating one will help doctors understand the current state of myeloma care in Italy, identify gaps, and prepare for advances in treatment.
You likely qualify if…
You likely don't qualify if…
If you join, your doctors will share information about your myeloma diagnosis, treatments, and health outcomes with the registry using a secure online system. You'll have check-in visits roughly every 6 months as part of your normal care. The study also welcomes your own input as a patient — your perspective and experiences matter. Participation is flexible and can continue even if you're enrolled in other myeloma studies.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
Italy